Health Care [ 3/12 ] | Health Care Equipment & Supplies [ 26/75 ]
NYSE | Common Stock
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.
It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands.
The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve.
It distributes its products through a direct sales force and independent distributors.
Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 10, 26 | 0.58 Decreased by -1.69% | 0.62 Decreased by -6.39% |
| Oct 30, 25 | 0.67 Increased by 0.00% | 0.59 Increased by +13.56% |
| Jul 22, 25 | 0.67 Decreased by -4.29% | 0.62 Increased by +7.53% |
| Apr 23, 25 | 0.64 Decreased by -3.03% | 0.60 Increased by +7.45% |
| Feb 4, 25 | 0.59 Decreased by -7.81% | 0.55 Increased by +6.38% |
| Oct 24, 24 | 0.67 Increased by +13.56% | 0.64 Increased by +4.69% |
| Jul 24, 24 | 0.70 Increased by +6.06% | 0.69 Increased by +1.45% |
| Apr 25, 24 | 0.66 Increased by +6.45% | 0.64 Increased by +3.13% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 1.57 B Increased by +13.26% | 91.20 M Decreased by -76.35% | Increased by +5.81% Decreased by -79.12% |
| Sep 30, 25 | 1.55 B Increased by +14.67% | 291.10 M Decreased by -90.52% | Increased by +18.74% Decreased by -91.73% |
| Jun 30, 25 | 1.53 B Increased by +10.56% | 329.80 M Decreased by -9.32% | Increased by +21.52% Decreased by -17.98% |
| Mar 31, 25 | 1.41 B Increased by +6.23% | 358.00 M Increased by +1.73% | Increased by +25.34% Decreased by -4.23% |
| Dec 31, 24 | 1.39 B Increased by +9.43% | 385.60 M Increased by +4.24% | Increased by +27.83% Decreased by -4.74% |
| Sep 30, 24 | 1.35 B Increased by +8.93% | 3.07 B Increased by +697.82% | Increased by +226.73% Increased by +632.43% |
| Jun 30, 24 | 1.39 B Increased by +6.98% | 363.70 M Increased by +18.43% | Increased by +26.24% Increased by +10.71% |
| Mar 31, 24 | 1.33 B Decreased by -8.89% | 351.90 M Increased by +3.35% | Increased by +26.46% Increased by +13.43% |